Castrate-resistant Prostate Cancer Market Size, Share & Trends Report

Castrate-resistant Prostate Cancer Market Size, Share & Trends Analysis Report By Therapy (Chemotherapy, Hormonal Therapy, Immunotherapy, Radiotherapy), By Region, And Segment Forecasts, 2025 - 2030

Report ID: GVR-4-68039-237-3
Number of Report Pages: 90
Format: PDF, Horizon Databook

Historical Range: 2018 - 2023
Forecast Period: 2025 - 2030
Industry: Healthcare

Market Segmentation

Castrate-resistant Prostate Cancer Therapy Outlook (Revenue, USD Million, 2018 - 2030)
- Chemotherapy
- Hormonal Therapy
- Immunotherapy
- Radiotherapy
Castrate-resistant Prostate Cancer Regional Outlook (Revenue, USD Million, 2018 – 2030)
- North America
  - North America castrate-resistant prostate cancer market, by therapy
    - Chemotherapy
    - Hormonal Therapy
    - Immunotherapy
    - Radiotherapy
  - U.S.
    - U.S. castrate-resistant prostate cancer market, by therapy
      - Chemotherapy
      - Hormonal Therapy
      - Immunotherapy
      - Radiotherapy
  - Canada
    - Canada castrate-resistant prostate cancer market, by therapy
      - Chemotherapy
      - Hormonal Therapy
      - Immunotherapy
      - Radiotherapy
  - Mexico
    - Mexico castrate-resistant prostate cancer market, by therapy
      - Chemotherapy
      - Hormonal Therapy
      - Immunotherapy
      - Radiotherapy
- Europe
  - Europe castrate-resistant prostate cancer market, by therapy
    - Chemotherapy
    - Hormonal Therapy
    - Immunotherapy
    - Radiotherapy
  - UK
    - UK castrate-resistant prostate cancer market, by therapy
      - Chemotherapy
      - Hormonal Therapy
      - Immunotherapy
      - Radiotherapy
  - Germany
    - Germany castrate-resistant prostate cancer market, by therapy
      - Chemotherapy
      - Hormonal Therapy
      - Immunotherapy
      - Radiotherapy
  - France
    - France castrate-resistant prostate cancer market, by therapy
      - Chemotherapy
      - Hormonal Therapy
      - Immunotherapy
      - Radiotherapy
  - Italy
    - Italy castrate-resistant prostate cancer market, by therapy
      - Chemotherapy
      - Hormonal Therapy
      - Immunotherapy
      - Radiotherapy
  - Spain
    - Spain castrate-resistant prostate cancer market, by therapy
      - Chemotherapy
      - Hormonal Therapy
      - Immunotherapy
      - Radiotherapy
  - Norway
    - Norway castrate-resistant prostate cancer market, by therapy
      - Chemotherapy
      - Hormonal Therapy
      - Immunotherapy
      - Radiotherapy
  - Sweden
    - Sweden castrate-resistant prostate cancer market, by therapy
      - Chemotherapy
      - Hormonal Therapy
      - Immunotherapy
      - Radiotherapy
  - Denmark
    - Denmark castrate-resistant prostate cancer market, by therapy
      - Chemotherapy
      - Hormonal Therapy
      - Immunotherapy
      - Radiotherapy
- Asia Pacific
  - Asia Pacific castrate-resistant prostate cancer market, by therapy
    - Chemotherapy
    - Hormonal Therapy
    - Immunotherapy
    - Radiotherapy
  - Japan
    - Japan castrate-resistant prostate cancer market, by therapy
      - Chemotherapy
      - Hormonal Therapy
      - Immunotherapy
      - Radiotherapy
  - China
    - China castrate-resistant prostate cancer market, by therapy
    - Chemotherapy
      - Hormonal Therapy
      - Immunotherapy
      - Radiotherapy
  - India
    - India castrate-resistant prostate cancer market, by therapy
      - Chemotherapy
      - Hormonal Therapy
      - Immunotherapy
      - Radiotherapy
  - Thailand
    - Thailand castrate-resistant prostate cancer market, by therapy
      - Chemotherapy
      - Hormonal Therapy
      - Immunotherapy
      - Radiotherapy
  - South Korea
    - South Korea castrate-resistant prostate cancer market, by therapy
      - Chemotherapy
      - Hormonal Therapy
      - Immunotherapy
      - Radiotherapy
  - Australia
    - Australia castrate-resistant prostate cancer market, by therapy
      - Chemotherapy
      - Hormonal Therapy
      - Immunotherapy
      - Radiotherapy
- Latin America
  - Latin America castrate-resistant prostate cancer market, by therapy
    - Chemotherapy
    - Hormonal Therapy
    - Immunotherapy
    - Radiotherapy
  - Brazil
    - Brazil castrate-resistant prostate cancer market, by therapy
      - Chemotherapy
      - Hormonal Therapy
      - Immunotherapy
      - Radiotherapy
  - Argentina
    - Argentina castrate-resistant prostate cancer market, by therapy
      - Chemotherapy
      - Hormonal Therapy
      - Immunotherapy
      - Radiotherapy
- Middle East & Africa
  - Middle East & Africa castrate-resistant prostate cancer market, by therapy
    - Chemotherapy
    - Hormonal Therapy
    - Immunotherapy
    - Radiotherapy
  - South Africa
    - South Africa castrate-resistant prostate cancer market, by therapy
      - Chemotherapy
      - Hormonal Therapy
      - Immunotherapy
      - Radiotherapy
  - Saudi Arabia
    - Saudi Arabia castrate-resistant prostate cancer market, by therapy
      - Chemotherapy
      - Hormonal Therapy
      - Immunotherapy
      - Radiotherapy
  - UAE
    - UAE castrate-resistant prostate cancer market, by therapy
      - Chemotherapy
      - Hormonal Therapy
      - Immunotherapy
      - Radiotherapy
  - Kuwait
    - Kuwait castrate-resistant prostate cancer market, by therapy
      - Chemotherapy
      - Hormonal Therapy
      - Immunotherapy
      - Radiotherapy

Report content

Qualitative Analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments

Quantitative Analysis

Market size, estimates, and forecast from 2018 to 2030
Market estimates and forecast for product segments up to 2030
Regional market size and forecast for product segments up to 2030
Market estimates and forecast for application segments up to 2030
Regional market size and forecast for application segments up to 2030
Company financial performance

GET A FREE SAMPLE

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

Or view our licence options:

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

ESOMAR certified & member

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.